Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.

Congratulations Laura and Roger, and keep up the good work!

More details? Click here.

OTHER NEWS

Noticias Premios

Premis Ciutat de Barcelona – 2024

Los Premios Ciudad de Barcelona, otorgados por el Ayuntamiento de Barcelona, reconocen la crecaión artística y cultural unida a la…

Noticias Premios

Premios Rei Jaume I – 2024

Tres Profesores de Investigación ICREA reciben el Premio Rei Jaume I en la 37ª edición de este galardón. Muchas felicidades…